EGFR and breast cancer: The 26 pathways detected in both datasets included many pathways known to be deregulated in breast cancer pathogenesis, such as cell cycle, apoptosis, Jak-STAT, MAPK, ErbB, Wnt and P53 signalling pathways [38].